Drug Shortage Report for PMS-TOPOTECAN

Last updated on 2020-04-02 History
Report ID 1969
Drug Identification Number 02406446
Brand name PMS-TOPOTECAN
Common or Proper name Topotecan
Company Name PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) TOPOTECAN
Strength(s) 4MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 1
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2015-07-20
Estimated end date Unknown
Actual end date 2020-04-01
Shortage status Resolved
Updated date 2020-04-02
Company comments Product to be discontinued
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-04-02 French Compare
v9 2020-04-02 English Compare
v8 2019-01-16 French Compare
v7 2019-01-16 English Compare
v6 2019-01-16 French Compare
v5 2019-01-16 English Compare
v4 2017-03-13 French Compare
v3 2017-03-13 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare

Showing 1 to 10 of 10